Arch Therapeutics, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
Arch Therapeutics has filed an amendment to its annual report to correct disclosures regarding beneficial ownership of shares by certain shareholders, directors, and officers.
Arch Therapeutics reports its fiscal year 2023 results, highlighting increased revenue but also significant losses and substantial doubt about its ability to continue as a going concern.